PowerPort Sepsis and Infection Risk

How a Catheter Fragment Causes Persistent Infection

Foreign bodies in the bloodstream — including fractured catheter fragments — are rapidly colonized by bacteria that adhere to the polymer surface and produce a polysaccharide matrix called a biofilm. Biofilm-encased bacteria are protected from both the immune system's phagocytic cells and antibiotic penetration, making infections associated with intravascular foreign bodies notoriously refractory to antibiotic treatment alone. The biofilm continuously sheds planktonic (free-floating) bacteria into the bloodstream, causing persistent or relapsing bacteremia that returns each time antibiotic therapy is discontinued.

Staphylococcus aureus (including methicillin-resistant S. aureus, MRSA) and coagulase-negative staphylococci (such as S. epidermidis) are the organisms most commonly associated with catheter-related foreign body infections. S. aureus bacteremia is particularly dangerous because it carries a high rate of metastatic infection — seeding bacteria to distant sites including the heart valves (endocarditis), bones (osteomyelitis), joints (septic arthritis), kidneys (renal abscess), and brain (cerebral abscess). Each of these metastatic complications represents an additional organ system injury with its own treatment course and long-term consequences.

Infective Endocarditis — The Cardiac Infection Complication

Infective endocarditis (IE) occurs when bacteria from a catheter fragment colonize the endothelial lining of the heart valves, forming bulky vegetations on the valve leaflets. Because fractured PowerPort catheter fragments typically reside in the right heart, the tricuspid and pulmonary valves are at particular risk. Tricuspid valve endocarditis causes valvular regurgitation (backward leakage of blood) and may require cardiac surgery for valve repair or replacement. Septic pulmonary emboli — vegetations that break off and travel to the lungs — cause multiple areas of pulmonary infarction, presenting as fever, chest pain, and new pulmonary infiltrates on imaging.

Treatment of catheter-related endocarditis requires 6 weeks of intravenous antibiotics per American Heart Association guidelines, typically administered through a peripherally inserted central catheter in the outpatient setting after initial hospital stabilization. Patients with refractory endocarditis, severe valvular destruction, or persistent bacteremia despite antibiotics require cardiac surgery. The physical and psychological toll of endocarditis — prolonged IV antibiotic therapy, surgical risk, extended recovery, and the fear of relapse — are all components of compensable damages in a PowerPort lawsuit.

Heightened Risk for Immunocompromised Cancer Patients

The population most likely to have a PowerPort implanted — cancer patients receiving chemotherapy — is precisely the population at highest risk for serious infectious complications from a catheter fracture. Chemotherapy agents destroy rapidly dividing cells including neutrophils, the white blood cells primarily responsible for bacterial killing. Neutropenic (low white blood cell count) patients have dramatically impaired ability to contain bacteremia, making infections that a healthy person might control rapidly life-threatening in chemotherapy patients. Many PowerPort fracture victims are cancer survivors who believed their cancer battle was behind them, only to face a life-threatening infection years later from a device they trusted for their treatment.